DUBLIN--(BUSINESS WIRE)--The "Implantable Drug Delivery Devices Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.
The global implantable drug delivery devices market was worth USD 13,499.43 million in 2017 and it is projected to reach USD 20,589.07 million in 2024, expanding at a CAGR of 6.22% between 2018 and 2024.
The global implantable drug delivery devices market is set to experience substantial growth over the forecast period. Primarily driven by increasing population, rise in number of cancer cases, growing number of cardiology, ophthalmology abnormalities, trend of contraception and technological advancements. On the other hand, the risk of infection, risk of overdose/under-dose due to technical difficulty of the devices, high cost will likely to restrain the growth of the market. Merger and acquisition activities among leading service providers will enlighten the opportunities for the same market for the growth over the forecast period.
According to the World Health Organization (WHO), around 30% of the deaths occurred from cardiovascular disease (particularly from coronary heart disease) across worldwide and the number of cases has been rapidly growing. In addition, the worldwide prevalence of glaucoma varies from 2% to 6%, (found highest in the South Africa). In South Korea, prevalence of glaucoma has been increased 54% between 2008 and 2013.
- Boston Scientific Corporation
- Bayer AG
- Alimera Sciences
- Eyepoint Pharmaceuticals
- Mecrk & Co., Inc
- Valeant Pharmaceuticals
Key Topics Covered:
2. Executive Summary
3. Global Implantable drug delivery devices Market Overview
4. Global Implantable drug delivery devices market by Product Type
5. Global Implantable drug delivery devices Market by Technology
6. Global Implantable drug delivery devices Market by Applications
7. Global Implantable drug delivery devices Market by Region 2018-2024
8. Company Covered
For more information about this report visit https://www.researchandmarkets.com/research/46cvcb/global?w=4